SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

Gustavo Alva, MD, DFAPA

Speaker Affiliation

Course Director
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

Gustavo Alva, MD, DFAPA
Medical Director, ATP Clinical Research
Volunteer Faculty
(Assistant Clinical Professor)
Department of Psychiatry
University of California
Riverside, CA

: Pseudobulbar Affect: A Call to Action
Activity/Course #:
: NCME337
: Free
Release/Start Date:
: Nov 06 2017
Expiration Date:
: Nov 05 2018
: Psychiatry
Target Audience:
: Primary Care Providers
: Webcast
Estimated Time To Complete CME Activity:
: 1.25 Hours
: 1.25 AMA PRA Category I Credit(s)
1.25 AANP Contact hour(s) which includes .25 pharmacology hour(s)
Hardware/Software Requirements:
Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care 2017 conference.

Pseudobulbar affect (PBA) is a neurologic syndrome of emotional affect disinhibition, characterized by frequent, uncontrollable emotional outbursts of crying and/or laughing that are usually exaggerated and inappropriate to the stimulus, and may be mood incongruent. Although the etiology of PBA is unclear, the condition is believed to be caused by the presence of brain lesions interfering with neural circuits and neurotransmitters that regulate voluntary and perhaps over-learned involuntary emotional expression. PBA may cause severe distress, embarrassment, and social disability among patients. Despite the availability of effective treatment for PBA, the condition remains undertreated.

In this activity, Dr. Alva will discuss how to effectively recognize, diagnose and treat patients with PBA. Incorporated into this program are video clips of real patients with PBA demonstrating characteristic laughing and crying episodes to help bring this diagnosis to life.

The webcast was recorded live and is being used with the permission of the presenter.

Learning Objective(s):

After completing this program participants should be able to:

  1. Review the epidemiology and impact of Pseudobulbar Affect (PBA).
  2. Recognize the importance of early recognition of PBA in primary care.
  3. Describe diagnostic tools and criteria for objective diagnosis of PBA.
  4. Discuss therapeutic options for PBA.

How To Obtain Your CME Certificate

  1. Register for the course at
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.25 contact hours of continuing education (which includes 0.25 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Gustavo Alva, MD, DFAPA serves on the research support team for Intra-Cellular, Trans-Tech, Novartis, and Neurion. Dr. Alva also serves on the clinical research team for Suven, Neurotrope, Janssen, Allergan, and Lundbeck.

Gregg Sherman, MD, Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an an educational grant from Avanir Pharmaceuticals.